1. Home
  2. AVDL vs BLMN Comparison

AVDL vs BLMN Comparison

Compare AVDL & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • BLMN
  • Stock Information
  • Founded
  • AVDL 2015
  • BLMN 1988
  • Country
  • AVDL Ireland
  • BLMN United States
  • Employees
  • AVDL N/A
  • BLMN N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • BLMN Restaurants
  • Sector
  • AVDL Health Care
  • BLMN Consumer Discretionary
  • Exchange
  • AVDL Nasdaq
  • BLMN Nasdaq
  • Market Cap
  • AVDL 784.6M
  • BLMN 714.5M
  • IPO Year
  • AVDL 1996
  • BLMN 2012
  • Fundamental
  • Price
  • AVDL $9.18
  • BLMN $9.51
  • Analyst Decision
  • AVDL Strong Buy
  • BLMN Hold
  • Analyst Count
  • AVDL 6
  • BLMN 11
  • Target Price
  • AVDL $18.17
  • BLMN $13.25
  • AVG Volume (30 Days)
  • AVDL 1.3M
  • BLMN 2.4M
  • Earning Date
  • AVDL 08-07-2025
  • BLMN 08-05-2025
  • Dividend Yield
  • AVDL N/A
  • BLMN 6.33%
  • EPS Growth
  • AVDL N/A
  • BLMN N/A
  • EPS
  • AVDL N/A
  • BLMN N/A
  • Revenue
  • AVDL $194,450,000.00
  • BLMN $3,930,996,000.00
  • Revenue This Year
  • AVDL $56.88
  • BLMN $1.28
  • Revenue Next Year
  • AVDL $29.81
  • BLMN $1.55
  • P/E Ratio
  • AVDL N/A
  • BLMN $9.92
  • Revenue Growth
  • AVDL 252.64
  • BLMN N/A
  • 52 Week Low
  • AVDL $6.38
  • BLMN $6.09
  • 52 Week High
  • AVDL $17.30
  • BLMN $21.45
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 47.63
  • BLMN 62.16
  • Support Level
  • AVDL $9.10
  • BLMN $8.90
  • Resistance Level
  • AVDL $9.76
  • BLMN $9.65
  • Average True Range (ATR)
  • AVDL 0.47
  • BLMN 0.54
  • MACD
  • AVDL -0.08
  • BLMN 0.17
  • Stochastic Oscillator
  • AVDL 14.29
  • BLMN 93.99

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

Share on Social Networks: